| 000 | 01876 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517071918.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.02302-15 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaunders, David L | |
| 245 | 0 | 0 |
_aAtovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cDec 2015 |
||
| 300 |
_a1896-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntimalarials _xtherapeutic use |
| 650 | 0 | 4 |
_aArtemisinins _xtherapeutic use |
| 650 | 0 | 4 |
_aAtovaquone _xtherapeutic use |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aCambodia |
| 650 | 0 | 4 |
_aDNA, Protozoan _xgenetics |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMalaria, Falciparum _xdrug therapy |
| 650 | 0 | 4 | _aParasitic Sensitivity Tests |
| 650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
| 650 | 0 | 4 |
_aProguanil _xtherapeutic use |
| 650 | 0 | 4 |
_aQuinolines _xtherapeutic use |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 | _aThailand |
| 700 | 1 | _aChaorattanakawee, Suwanna | |
| 700 | 1 | _aGosi, Panita | |
| 700 | 1 | _aLanteri, Charlotte | |
| 700 | 1 | _aSomethy, Sok | |
| 700 | 1 | _aKuntawunginn, Worachet | |
| 700 | 1 | _aIttiverakul, Mali | |
| 700 | 1 | _aChann, Soklyda | |
| 700 | 1 | _aGregory, Carrie | |
| 700 | 1 | _aChuor, Char Meng | |
| 700 | 1 | _aProm, Satharath | |
| 700 | 1 | _aSpring, Michele D | |
| 700 | 1 | _aLon, Chanthap | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 60 _gno. 3 _gp. 1896-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.02302-15 _zAvailable from publisher's website |
| 999 |
_c25582392 _d25582392 |
||